tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

EWTX Stock Latest News

Edgewise Therapeutics Promotes Derakhshan to COO Role
Company AnnouncementsEdgewise Therapeutics Promotes Derakhshan to COO Role
11d ago
8K
EWTX
Edgewise Therapeutics promotes Behrad Derakhshan to COO
PremiumThe Fly
Edgewise Therapeutics promotes Behrad Derakhshan to COO
11d ago
MRK
EWTX
Edgewise Therapeutics initiated with a Hold at Stifel
PremiumThe Fly
Edgewise Therapeutics initiated with a Hold at Stifel
11d ago
EWTX
Edgewise Therapeutics price target raised to $50 from $45 at Evercore ISI
PremiumThe Fly
Edgewise Therapeutics price target raised to $50 from $45 at Evercore ISI
2M ago
EWTX
Edgewise Therapeutics Reports Promising Phase 2 Trial Results
PremiumCompany Announcements
Edgewise Therapeutics Reports Promising Phase 2 Trial Results
2M ago
8K
EWTX
Edgewise Therapeutics price target raised to $50 from $44 at Leerink
PremiumThe FlyEdgewise Therapeutics price target raised to $50 from $44 at Leerink
2M ago
EWTX
Morning Movers: Viridian and Edgewise jump following successful trials
Premium
The Fly
Morning Movers: Viridian and Edgewise jump following successful trials
2M ago
F
HON
Edgewise reports CANYON Phase 2 trial of sevasemten meets primary endpoint
Premium
The Fly
Edgewise reports CANYON Phase 2 trial of sevasemten meets primary endpoint
2M ago
EWTX
Edgewise weakness on FDA warning letter ‘unwarranted,’ says RBC Capital
PremiumThe Fly
Edgewise weakness on FDA warning letter ‘unwarranted,’ says RBC Capital
2M ago
EWTX
Edgewise says FDA warning letter unrelated to any Edgewise clinical trial, data
PremiumThe Fly
Edgewise says FDA warning letter unrelated to any Edgewise clinical trial, data
2M ago
EWTX
Edgewise moves off lows after stating FDA warning unrelated to company
PremiumThe Fly
Edgewise moves off lows after stating FDA warning unrelated to company
2M ago
EWTX
Edgewise should be bought on weakness as ARCH not likely FDA focus, says Truist
PremiumThe Fly
Edgewise should be bought on weakness as ARCH not likely FDA focus, says Truist
2M ago
APLT
EWTX
Edgewise falls after FDA posts Warning Letter to trial investigator
PremiumThe FlyEdgewise falls after FDA posts Warning Letter to trial investigator
2M ago
EWTX
Edgewise Therapeutics price target raised to $50 from $33 at Truist
Premium
The Fly
Edgewise Therapeutics price target raised to $50 from $33 at Truist
2M ago
EWTX
Edgewise Therapeutics initiated with an Outperform at Evercore ISI
Premium
The Fly
Edgewise Therapeutics initiated with an Outperform at Evercore ISI
2M ago
EWTX
Edgewise Therapeutics Reports Q3 Progress in Muscle Disease Trials
PremiumCompany Announcements
Edgewise Therapeutics Reports Q3 Progress in Muscle Disease Trials
3M ago
EWTX
Edgewise Therapeutics reports Q3 EPS (36c), consensus (37c)
PremiumThe Fly
Edgewise Therapeutics reports Q3 EPS (36c), consensus (37c)
3M ago
EWTX
Edgewise Therapeutics call volume above normal and directionally bullish
PremiumThe Fly
Edgewise Therapeutics call volume above normal and directionally bullish
4M ago
EWTX
Edgewise Therapeutics price target raised to $51 from $48 at Piper Sandler
PremiumThe Fly
Edgewise Therapeutics price target raised to $51 from $48 at Piper Sandler
4M ago
EWTX
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
4M ago
USO
ACHR
Edgewise Therapeutics put volume heavy and directionally bearish
Premium
The Fly
Edgewise Therapeutics put volume heavy and directionally bearish
4M ago
EWTX
Edgewise Therapeutics price target raised to $42 from $32 at RBC Capital
Premium
The Fly
Edgewise Therapeutics price target raised to $42 from $32 at RBC Capital
4M ago
EWTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >